Research Study

Preemptive Therapy for SARS-Coronavirus-2
Principal Investigator 
Sara Belga

Overview

Body Locations and Systems 
Immune System
ClinicalTrials.gov# 
NCT04308668
Status 
Recruiting
Study Start/End 
May 27, 2020 to Oct 31, 2020
Locations 
Vancouver Community
Name/Title 
Dr. Sara Belga
Phone 
604-875-4588
Email Address 
sara.belga@ubc.ca
Purpose of Study 

The purpose of this study is to test if early treatment with hydroxychloroquine can prevent the progression of symptoms in a person with known symptomatic COVID-19 disease.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.